HomeCompareRVVTF vs GBDC

RVVTF vs GBDC: Dividend Comparison 2026

RVVTF yields 7692.31% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RVVTF wins by $4177739098279568.00M in total portfolio value
10 years
RVVTF
RVVTF
● Live price
7692.31%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4177739098279589.00M
Annual income
$4,073,565,928,588,968,500,000.00
Full RVVTF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — RVVTF vs GBDC

📍 RVVTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRVVTFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RVVTF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RVVTF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RVVTF
Annual income on $10K today (after 15% tax)
$653,846.15/yr
After 10yr DRIP, annual income (after tax)
$3,462,531,039,300,623,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, RVVTF beats the other by $3,462,531,039,300,609,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RVVTF + GBDC for your $10,000?

RVVTF: 50%GBDC: 50%
100% GBDC50/50100% RVVTF
Portfolio after 10yr
$2088869549139805.00M
Annual income
$2,036,782,964,294,492,400,000.00/yr
Blended yield
97.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

RVVTF
No analyst data
Altman Z
-566.5
Piotroski
1/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RVVTF buys
0
GBDC buys
0
No recent congressional trades found for RVVTF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRVVTFGBDC
Forward yield7692.31%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$4177739098279589.00M$20.78M
Annual income after 10y$4,073,565,928,588,968,500,000.00$16,389,263.41
Total dividends collected$4170772265337663.00M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: RVVTF vs GBDC ($10,000, DRIP)

YearRVVTF PortfolioRVVTF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$779,931$769,230.77$12,490$1,790.28+$767.4KRVVTF
2$56,904,315$56,069,789.30$16,522$3,157.73+$56.89MRVVTF
3$3,884,151,673$3,823,264,055.84$23,578$5,898.68+$3884.13MRVVTF
4$248,050,254,929$243,894,212,638.74$37,115$11,886.75+$248050.22MRVVTF
5$14,822,056,221,428$14,556,642,448,653.80$66,136$26,423.57+$14822056.16MRVVTF
6$828,776,618,419,079$812,917,018,262,150.50$137,257$66,491.44+$828776618.28MRVVTF
7$43,367,472,132,823,630$42,480,681,151,115,220.00$341,734$194,868.54+$43367472132.48MRVVTF
8$2,123,871,047,251,591,000$2,077,467,852,069,469,400.00$1,050,788$685,133.02+$2123871047250.54MRVVTF
9$97,358,102,514,598,310,000$95,085,560,494,039,100,000.00$4,099,314$2,974,971.01+$97358102514594.22MRVVTF
10$4,177,739,098,279,589,000,000$4,073,565,928,588,968,500,000.00$20,775,530$16,389,263.41+$4177739098279568.00MRVVTF

RVVTF vs GBDC: Complete Analysis 2026

RVVTFStock

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has research collaboration agreements with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; North Carolina State University for the development of a biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform; the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19; University of Health Sciences Antigua for the clinical research of psychedelics; and PharmaTher for the development of psilocybin microneedle patch. The company was incorporated in 2012 and is headquartered in Toronto, Canada.

Full RVVTF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this RVVTF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RVVTF vs SCHDRVVTF vs JEPIRVVTF vs ORVVTF vs KORVVTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.